Apollomics remains listed on NASDAQ after compliance determination Oct 15, 2025 02:37PM
NASDAQ resumes trading in Apollomics shares and warrants Oct 14, 2025 04:06PM
Apollomics (APLM) Announces Top-line Results for Phase 3 Bridging Trial of Uproleselan in China Dec 20, 2024 08:01AM
Apollomics (APLM) Granted 180-Day Extension to Regain Compliance Jul 16, 2024 04:50PM